Thalidomide

CD4 molecule ; Homo sapiens







13 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35083901 The Immunomodulating Effects of Thalidomide and Dexamethasone in a Murine Cardiac Allograft Transplantation Model. 2022 Feb 1
2 28822719 Thalidomide is Associated With Increased T Cell Activation and Inflammation in Antiretroviral-naive HIV-infected Individuals in a Randomised Clinical Trial of Efficacy and Safety. 2017 Sep 3
3 24596000 Thalidomide regulation of NF-κB proteins limits Tregs activity in chronic lymphocytic leukemia. 2014 Jan-Feb 1
4 18034203 Thalidomide has both anti-inflammatory and regulatory effects in Behcet's disease. 2008 Mar 1
5 18549624 [Effects of thalidomide on CD4(+)CD25(+) T regulatory cells in patients with multiple myeloma]. 2008 Jun 7
6 17013434 [Thalidomide in treatment of connective diseases and vasculities]. 2006 Jul-Sep 1
7 16019550 The ratio between CD4+ and CD8+ cells in the peripheral blood of patients with hematological malignancies is not altered by thalidomide. 2005 Jul 1
8 12296856 Thalidomide and its analogues have distinct and opposing effects on TNF-alpha and TNFR2 during co-stimulation of both CD4(+) and CD8(+) T cells. 2002 Oct 2
9 12349951 Thalidomide can costimulate or suppress CD4+ cells' ability to incorporate [H3]-thymidine--dependence on the primary stimulant. 2002 Jul 7
10 10647875 Thalidomide's ability to augment the synthesis of IL-2 in vitro in HIV-infected patients is associated with the percentage of CD4+ cells in their blood. 2000 Feb 2
11 8931784 Effects of thalidomide on HIV-associated wasting syndrome: a randomized, double-blind, placebo-controlled clinical trial. 1996 Nov 1
12 7830502 Thalidomide and the immune system. 4. Down-regulation of the CD26 receptor, probably involved in the binding of HIV components to T cells in primates. 1995 2
13 1569817 Thalidomide's effectiveness in erythema nodosum leprosum is associated with a decrease in CD4+ cells in the peripheral blood. 1992 Mar 3